Trademarkia Logo

Canada

C$
Trademark Search in Canada
MYGENVIII

View On IC.GC.CA

MYGENVIII
REGISTERED

on 14 Jun 2024

TM5 Status

LIVE/REGISTRATION/Issued and Active

Your registration has been issued and is active. You can now use the TM5 mark.

Last Applicant/ Owned by

BAYER AKTIENGESELLSCHAFT

Kaiser-Wilhelm-Allee51373 Leverkusen

DE

Serial Number

2134028 filed on 26th Jul 2021

Registration Number

TMA1238148 registered on 14th Jun 2024

Registration expiry Date

26th Jul 2031

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

MYGENVIII

Trademark usage description

pharmaceutical products for the treatment of hematologic diseases; pharmaceutical products for the treatment of cardiovascular diseases; pharmaceutica Read More

Classification Information

Class [005]
Pharmaceutical products for the treatment of hematologic diseases; pharmaceutical products for the treatment of cardiovascular diseases; pharmaceutical products for the treatment of cancer; pharmaceutical products for the treatment of diabetes; anti-infectives.

Classification kind code

11

Mark Details

Serial Number

2134028

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 29th Jun 2023		Agent Changed
Submitted for opposition 22
on 3rd Jan 2023		Search Recorded
Submitted for opposition 20
on 3rd Jan 2023		Examiner's First Report
Submitted for opposition 223
on 3rd Jan 2023		Total Provisional Refusal
Submitted for opposition 256
on 18th Jul 2022		Notification of Possible Opposition Sent
Submitted for opposition 257
on 16th Sept 2021		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 16th Sept 2021		Created
Submitted for opposition 31
on 16th Sept 2021		Formalized
Submitted for opposition 30
on 26th Jul 2021		Filed
Submitted for opposition 228
on 26th Jul 2021		International Registration